NCT06796699View on ClinicalTrials.gov

A Phase Ia/Ib Clinical Study of GH56 Capsules in Subjects With MTAP-Deleted Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

March 7, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

February 29, 2028

Conditions
Advanced Solid Tumors With MTAP Gene Deletion
Interventions
DRUG

GH56 Capsule

GH56 capsule for oral administration at specified doses on scheduled days.

Trial Locations (4)

30009

NOT_YET_RECRUITING

Shanxi Provincial Cancer Hospital, Taiyuan

100021

RECRUITING

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

200233

NOT_YET_RECRUITING

Shanghai Sixth People's Hospital, Shanghai

201200

NOT_YET_RECRUITING

Shanghai GoBroad Caner Hospital China Pharmaceutical University, Shanghai

All Listed Sponsors
lead

Suzhou Genhouse Bio Co., Ltd.

OTHER